Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits

Tae Sung Park, Seung Tae Lee, Jaewoo Song, Kyung A. Lee, Jong Han Lee, Juwon Kim, Hyeon Ji Lee, Jeong Hyun Han, Jong Kee Kim, Sung Ran Cho, Jong Rak Choi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We report on a 20-year-old man with acute myeloid leukemia (AML) showing a distinct novel CBFB/MYH11 variant fusion transcript. Initial results of bone marrow, chromosome, and flow cytometric analyses were not in accordance with the diagnosis of acute myelomonocytic leukemia with eosinophilia (AML-M4Eo) or AML with a CBFB/MYH11 rearrangement. However, results from 2 commercially available multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) tests repeatedly showed an unusual PCR product from his bone marrow specimen. Not only does this case show a partial insertion of exon 6 of the CBFB (ENSG00000067955) gene, but it also involves novel breakpoints within both exon 6 of the CBFB gene and exon 28 (previously exon 7) of the MYH11 (ENSG00000133392) gene, which is regarded as a previously non-reported, new type (K-type) of CBFB/MYH11 fusion transcript. In addition, our study result was in agreement with the recent report of Schnittger et al. that rare fusion transcripts of CBFB/MYH11 are correlated with an atypical cytomorphology and other aberrant characteristics. Therefore, multiplex RT-PCR and sequence analysis of these atypical products should be performed to diagnose atypical AML with CBFB/MYH11 rearrangement, to predict prognosis of these patients as well as to elucidate the molecular mechanism.

Original languageEnglish
Pages (from-to)87-92
Number of pages6
JournalCancer genetics and cytogenetics
Volume189
Issue number2
DOIs
Publication statusPublished - 2009 Mar 1

Fingerprint

Multiplex Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Acute Myeloid Leukemia
Exons
Genes
Bone Marrow
Leukemia, Myelomonocytic, Acute
Eosinophilia
Sequence Analysis
Chromosomes
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Park, Tae Sung ; Lee, Seung Tae ; Song, Jaewoo ; Lee, Kyung A. ; Lee, Jong Han ; Kim, Juwon ; Lee, Hyeon Ji ; Han, Jeong Hyun ; Kim, Jong Kee ; Cho, Sung Ran ; Choi, Jong Rak. / Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits. In: Cancer genetics and cytogenetics. 2009 ; Vol. 189, No. 2. pp. 87-92.
@article{879b314f2dd6482b96c22ab6b375175e,
title = "Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits",
abstract = "We report on a 20-year-old man with acute myeloid leukemia (AML) showing a distinct novel CBFB/MYH11 variant fusion transcript. Initial results of bone marrow, chromosome, and flow cytometric analyses were not in accordance with the diagnosis of acute myelomonocytic leukemia with eosinophilia (AML-M4Eo) or AML with a CBFB/MYH11 rearrangement. However, results from 2 commercially available multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) tests repeatedly showed an unusual PCR product from his bone marrow specimen. Not only does this case show a partial insertion of exon 6 of the CBFB (ENSG00000067955) gene, but it also involves novel breakpoints within both exon 6 of the CBFB gene and exon 28 (previously exon 7) of the MYH11 (ENSG00000133392) gene, which is regarded as a previously non-reported, new type (K-type) of CBFB/MYH11 fusion transcript. In addition, our study result was in agreement with the recent report of Schnittger et al. that rare fusion transcripts of CBFB/MYH11 are correlated with an atypical cytomorphology and other aberrant characteristics. Therefore, multiplex RT-PCR and sequence analysis of these atypical products should be performed to diagnose atypical AML with CBFB/MYH11 rearrangement, to predict prognosis of these patients as well as to elucidate the molecular mechanism.",
author = "Park, {Tae Sung} and Lee, {Seung Tae} and Jaewoo Song and Lee, {Kyung A.} and Lee, {Jong Han} and Juwon Kim and Lee, {Hyeon Ji} and Han, {Jeong Hyun} and Kim, {Jong Kee} and Cho, {Sung Ran} and Choi, {Jong Rak}",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.cancergencyto.2008.10.012",
language = "English",
volume = "189",
pages = "87--92",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits. / Park, Tae Sung; Lee, Seung Tae; Song, Jaewoo; Lee, Kyung A.; Lee, Jong Han; Kim, Juwon; Lee, Hyeon Ji; Han, Jeong Hyun; Kim, Jong Kee; Cho, Sung Ran; Choi, Jong Rak.

In: Cancer genetics and cytogenetics, Vol. 189, No. 2, 01.03.2009, p. 87-92.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits

AU - Park, Tae Sung

AU - Lee, Seung Tae

AU - Song, Jaewoo

AU - Lee, Kyung A.

AU - Lee, Jong Han

AU - Kim, Juwon

AU - Lee, Hyeon Ji

AU - Han, Jeong Hyun

AU - Kim, Jong Kee

AU - Cho, Sung Ran

AU - Choi, Jong Rak

PY - 2009/3/1

Y1 - 2009/3/1

N2 - We report on a 20-year-old man with acute myeloid leukemia (AML) showing a distinct novel CBFB/MYH11 variant fusion transcript. Initial results of bone marrow, chromosome, and flow cytometric analyses were not in accordance with the diagnosis of acute myelomonocytic leukemia with eosinophilia (AML-M4Eo) or AML with a CBFB/MYH11 rearrangement. However, results from 2 commercially available multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) tests repeatedly showed an unusual PCR product from his bone marrow specimen. Not only does this case show a partial insertion of exon 6 of the CBFB (ENSG00000067955) gene, but it also involves novel breakpoints within both exon 6 of the CBFB gene and exon 28 (previously exon 7) of the MYH11 (ENSG00000133392) gene, which is regarded as a previously non-reported, new type (K-type) of CBFB/MYH11 fusion transcript. In addition, our study result was in agreement with the recent report of Schnittger et al. that rare fusion transcripts of CBFB/MYH11 are correlated with an atypical cytomorphology and other aberrant characteristics. Therefore, multiplex RT-PCR and sequence analysis of these atypical products should be performed to diagnose atypical AML with CBFB/MYH11 rearrangement, to predict prognosis of these patients as well as to elucidate the molecular mechanism.

AB - We report on a 20-year-old man with acute myeloid leukemia (AML) showing a distinct novel CBFB/MYH11 variant fusion transcript. Initial results of bone marrow, chromosome, and flow cytometric analyses were not in accordance with the diagnosis of acute myelomonocytic leukemia with eosinophilia (AML-M4Eo) or AML with a CBFB/MYH11 rearrangement. However, results from 2 commercially available multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) tests repeatedly showed an unusual PCR product from his bone marrow specimen. Not only does this case show a partial insertion of exon 6 of the CBFB (ENSG00000067955) gene, but it also involves novel breakpoints within both exon 6 of the CBFB gene and exon 28 (previously exon 7) of the MYH11 (ENSG00000133392) gene, which is regarded as a previously non-reported, new type (K-type) of CBFB/MYH11 fusion transcript. In addition, our study result was in agreement with the recent report of Schnittger et al. that rare fusion transcripts of CBFB/MYH11 are correlated with an atypical cytomorphology and other aberrant characteristics. Therefore, multiplex RT-PCR and sequence analysis of these atypical products should be performed to diagnose atypical AML with CBFB/MYH11 rearrangement, to predict prognosis of these patients as well as to elucidate the molecular mechanism.

UR - http://www.scopus.com/inward/record.url?scp=59649121560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649121560&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2008.10.012

DO - 10.1016/j.cancergencyto.2008.10.012

M3 - Article

C2 - 19215788

AN - SCOPUS:59649121560

VL - 189

SP - 87

EP - 92

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -